Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Cabozantinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Cabozantinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Cabozantinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Cabozantinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Cabozantinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Cabozantinib (Phenylene-d4) L-Malate Salt | Stable Isotopes | CS-T-99018 | Not Available | Enquire |
| Cabozantinib D4(FluoroBenzene-ring-d4) | Stable Isotopes | CS-EO-01503 | 1802168-53-1 | Enquire |
| Cabozantinib Intermediate-d6 | Stable Isotopes | CS-O-60159 | 1714998-85-2 | Enquire |
| Cabozantinib-d4 | Stable Isotopes | CS-AP-00013 | 849217-68-1 (Unlabeled) | In Stock |
| Cabozantinib-d6 | Stable Isotopes | CS-T-93996 | 1802168-46-2 | Enquire |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Cabozantinib | API Standards | CS-L-00116 | 849217-68-1 | In Stock |
| CABOZANTINIB FUMARATE | API Standards | CS-O-52726 | 849217-68-1(FREE BASE) | Enquire |
| Cabozantinib Hydrochloride | API Standards | CS-O-40640 | 1817759-42-4 | In Stock |
Metabolites
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Cabozantinib Metabolite M2a | Metabolites | CS-O-33941 | 1628530-37-9 | In Stock |
| Cabozantinib Metabolite M7 | Metabolites | CS-O-33939 | 849217-77-2 | In Stock |
| Cabozantinib Metabolite M9 | Metabolites | CS-O-33940 | 1628530-38-0 | In Stock |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 4-((6,7-dimethoxyquinolin-4-yl)amino)phenol | Impurities | CS-O-40386 | 748707-58-6 | Enquire |
| 4-(4-aminophenoxy)-6-methoxyquinolin-7-ol | Impurities | CS-O-40387 | 1355031-15-0 | Enquire |
| 6,7-dimethoxy-4-(4-nitrophenoxy)quinoline | Impurities | CS-EO-01744 | 190728-24-6 | Enquire |
| Cabozantinib Des Fluoro Impurity | Impurities | CS-EO-01700 | 849221-94-9 | In Stock |
| Cabozantinib Dimer Impurity | Impurities | CS-EO-02003 | Not Available | Enquire |
| Cabozantinib 2 fluoro impurity | Impurities | CS-O-41305 | Not Available | In Stock |
| Cabozantinib 3 fluoro impurity | Impurities | CS-O-41304 | Not Available | In Stock |
| Cabozantinib 6-Hydroxy impurity | Impurities | CS-O-52286 | 1628530-47-1 | Enquire |
| Cabozantinib Chloro Impurity | Impurities | CS-O-58214 | Not Available | Enquire |
| Cabozantinib Dimer Impurity | Impurities | CS-O-49320 | Not Available | Enquire |
| Cabozantinib Hydroxy Impurity | Impurities | CS-O-40991 | 849217-60-3 | In Stock |
| Cabozantinib Impurity 16 | Impurities | CS-EO-02842 | 2439164-91-5 | In Stock |
| Cabozantinib Impurity 22 | Impurities | CS-O-44877 | Not Available | Enquire |
| Cabozantinib Impurity 23 | Impurities | CS-O-44880 | Not Available | Enquire |
| Cabozantinib Impurity 24 | Impurities | CS-O-56627 | 145591-80-6 | In Stock |
| Cabozantinib Impurity 29 | Impurities | CS-O-56623 | 190728-26-8 | In Stock |
| Cabozantinib Impurity 30 | Impurities | CS-O-56624 | 202917-04-2 | Enquire |
| Cabozantinib Impurity 31 | Impurities | CS-O-56626 | 202917-05-3 | Enquire |
| Cabozantinib Impurity 32 | Impurities | CS-O-56629 | 1247859-37-5 | In Stock |
| Cabozantinib Impurity 33 | Impurities | CS-O-56630 | 190728-27-9 | Enquire |
| Cabozantinib Impurity 35 | Impurities | CS-O-58207 | 2458244-61-4 | Enquire |
| Cabozantinib Impurity 38 | Impurities | CS-O-58924 | Not Available | Enquire |
| Cabozantinib Impurity 6 | Impurities | CS-EO-01701 | Not Available | In Stock |
| Cabozantinib L-Malate impurity | Impurities | CS-O-44679 | Not Available | Enquire |
| Cabozantinib Malate (RACEMIC) impurity | Impurities | CS-O-44878 | Not Available | Enquire |
| Cabozantinib N-oxide | Impurities | CS-T-93426 | 1621681-63-7 | In Stock |
| Cabozantinib urea dimer | Impurities | CS-O-44677 | 2840522-81-6 | Enquire |
| Methyl 1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxyla... | Impurities | CS-O-44678 | 1345847-71-3 | Enquire |
Intermediates
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid | Intermediates | CS-O-32098 | 849217-48-7 | In Stock |
| 4-Hydroxy-6,7-dimethoxyqunioline | Intermediates | CS-AD-00707 | 13425-93-9 | In Stock |
| 6,7-Dimethoxy-4-(4-aminophenoxy)quinoline | Intermediates | CS-O-32099 | 190728-25-7 | In Stock |
| Cabozantinib Impurity 25 | Intermediates | CS-ED-30117 | 918642-61-2 | In Stock |
| Cabozantinib Impurity 5 | Intermediates | CS-BX-02571 | 1431468-36-8 | In Stock |
| Cabozantinib Intermediate | Intermediates | CS-M-42450 | 35654-56-9 | In Stock |
| Cabozantinib L-Malate Salt | Intermediates | CS-T-50185 | 1140909-48-3 | Enquire |
Glucuronides
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Desmethylcabozantinib Glucuronide A | Glucuronides | CS-O-46218 | Not Available | Enquire |
| Desmethylcabozantinib Glucuronide B | Glucuronides | CS-O-46219 | Not Available | Enquire |
| Desquinolinylcabozantinib glucuronide | Glucuronides | CS-O-46220 | 1628530-43-7 | Enquire |